We Improve the Discoverability of Press Releases
NewsRamp™ is the PR and Newswire technology platform that transforms press releases into AI-optimized and multi-modal unique content formats designed to maximize discovery, engagement and global reach. NewsRamp™ primarily services newswires and news publishers.
Latest News
New Book 'Scam Proof for Seniors' Fights Rising Digital Fraud
about 3 hours ago
LIXTE Acquires Liora's LiGHT System to Advance Cancer Therapy
about 6 hours ago
Renewal Fuels Appoints Fusion Expert Dr. John Brandenburg as CTO
about 7 hours ago
Silver Plunges 20% Amid Market Volatility, Testing Rally's End
about 7 hours ago
HR News
JDXpert Launches JDX+: AI-Powered Platform Solves Job Data Chaos
5 days ago
HR Study: Talent Acquisition Crisis Costs Firms Billions, AI Offers Hope
5 days ago
OrangeHRM 8.0 Launches with Citra AI to Transform HR into Culture Architects
6 days ago
HR.com Partners with VirgilHR to Revolutionize HR Compliance Technology
7 days ago
AI Hiring Bias Exposed: New 2026 Laws Protect Job Seekers from Algorithmic Discrimination
8 days ago
Business News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 8 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 8 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 4 months
XTI Aerospace Projects 30% Growth, Unveils 2026 Revenue Guidance Post-Drone Nerds Acquisition
about 2 hours ago
LIXTE Acquires Liora's LiGHT System to Advance Cancer Therapy
about 6 hours ago
Crypto News
Crypto Market Plunge Continues as Experts Warn of Further Declines
about 7 hours ago
White House Crypto Meeting Fails to Break Regulatory Stalemate
3 days ago
SOLOWIN Expands Digital Asset Operations into Korea and Japan
4 days ago
Blockchain Fuels Copper Tokenization Surge as Metals Market Evolves
4 days ago
Chinese Crime Networks Linked to $16B Crypto Crimes in Chainalysis Report
4 days ago
Health News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 8 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 8 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 4 months
LIXTE's LB-100 Compound Could Revolutionize Cancer Treatment Effectiveness
33 minutes ago
LIXTE Acquires Liora's LiGHT System to Advance Cancer Therapy
about 6 hours ago
Technology News
XTI Aerospace Projects 30% Growth, Unveils 2026 Revenue Guidance Post-Drone Nerds Acquisition
about 2 hours ago
LIXTE Acquires Liora's LiGHT System to Advance Cancer Therapy
about 6 hours ago
Oragenics Advances Intranasal Brain Therapy for Concussion Toward Phase 2 Trials
about 7 hours ago
Renewal Fuels Appoints Fusion Expert Dr. John Brandenburg as CTO
about 7 hours ago
ParaZero Showcases Counter-Drone Tech at Germany's Premier Defense Expo
about 7 hours ago
Events & Conferences
Safe Pro Group to Showcase AI Defense Tech at Key 2026 Military Conference
about 5 hours ago
ParaZero Showcases Counter-Drone Tech at Germany's Premier Defense Expo
about 7 hours ago
CleanGo Joins Canada-Saudi Trade Mission to Advance Green Tech Solutions
about 10 hours ago
California Tortilla Launches CalTort Games with Mystery Rewards
about 13 hours ago
SuperReturn North America 2026: Top PE & VC Leaders Converge in Miami
about 13 hours ago